GETTING MY SEMAGLUTIDE 2 MG TO WORK

The trial obtained the two its Major endpoints, with semaglutide two.four mg demonstrating statistically important and top-quality enhancements in liver fibrosis without any worsening of steatohepatitis, in addition to resolution of steatohepatitis with no worsening of liver fibrosis in people with MASH compared to placebo.1Mounjaro can be used as